Electrospun Poly(L-Lactide) Fiber with Ginsenoside Rg3 for Inhibiting Scar Hyperplasia of Skin

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Cui, Wenguo ^a   Cheng, Liying ^b   Hu, Changmin ^a   Li, Haiyan ^a   Zhang, Yuguang ^b   Chang, Jiang ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE RG 3; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EPIDERMIS; EXPERIMENTAL RABBIT; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERPLASIA; HYPERTROPHIC SCAR; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; POROSITY; SCANNING ELECTRON MICROSCOPY; SCAR FORMATION; SKINFOLD THICKNESS;

ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CICATRIX, HYPERTROPHIC; COLLAGEN; FIBROBLASTS; GINSENOSIDES; HUMANS; MICROSCOPY, ELECTRON, SCANNING; POLYESTERS; RABBITS; SOLUBILITY; TISSUE SCAFFOLDS; X-RAY DIFFRACTION;

EID: 84880435950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068771     Document Type: Article

References (44)

1. Karagoz H, Yuksel F, Ulkur E, Evinc R, (2009) Comparison of efficacy of silicone gel, silicone gel sheeting, and topical onion extract including heparin and allantoin for the treatment of postburn hypertrophic scars. Burns 35: 1097-1103.
2. Varkey M, Ding J, Tredget EE, (2011) Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: Potential therapeutic targets for hypertrophic scar. Biomaterials 32: 7581-7591.
3. Kloeters O, Tandara A, Mustoe TA, (2007) Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 15: S40-S45.
4. Fumagalli M, Musso T, Vermi W, Scutera S, Daniele R, et al. (2007) Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol 16: 600-610.
5. Arakawa M, Hatmochi A, Mori Y, Mori K, Ueki H, et al. (1996) Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 134: 863-868.
6. Zhao Q, Zheng X, Jiang J, Zhou H, Hu P, (2010) Determination of ginsenoside Rg3 in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 878: 2266-2273.
7. Yue PY, Wong DY, Wu PK, Leung PY, Mak NK, et al. (2006) The angiosuppressive effects of 20 (R)-ginsenoside Rg3. Biochem Pharmacol 72: 437-445.
8. Hang L, Qishan M, (2011) Synergistic effects of ginsenoside Rg3 and cyclophosphamine on tumor growth and angiogenesis in lung cancer. Afr J Biotechnol 10: 10040-10044.
9. Kurokawa N, Ueda K, Tsuji M, (2010) Study of microvascular structure in keloid and hypertrophic scars: Density of microvessels and the efficacy of three-dimensional vascular imaging. J Plast Surg Hand Surg 44: 272-277.
10. Yoo HH, Yokozawa T, Satoh A, Kang KS, Kim HY, (2006) Effects of ginseng on the proliferation of human lung fibroblasts. Am J Chin Med 34: 137.
11. Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, et al. (2009) Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 9, 250.
12. Lau KKS, Gleason KK, (2007) All-dry synthesis and coating of methacrylic acid copolymers for controlled release. Macromol Biosci 7: 429-434.
13. Usov D, Sukhorukov GB, (2010) Dextran coatings for aggregation control of layer-by-layer assembled polyelectrolyte microcapsules. Langmuir 26: 12575-12584.
14. She Z, Antipina MN, Li J, Sukhorukov GB, (2010) Mechanism of protein release from polyelectrolyte multilayer microcapsules. Biomacromolecules 11: 1241-1247.
15. Qiu X, Leporatti S, Donath E, Möhwald H, (2001) Studies on the drug release properties of polysaccharide multilayers encapsulated ibuprofen microparticles. Langmuir 17: 5375-5380.
16. Li B, HY Y, Xin W, Gang Z, (2010) Preparation, release-control and cell apoptosis of C6 glioma cells in PEG-PLGA-Rg3 nanoparticles. Chem Res Chin Univ 26: 780-784.
17. Attele AS, Wu JA, Yuan CS, (1999) Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
18. Zhang Q, Kang X, Yang B, Wang J, Yang F, (2008) Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother Radiopharm 23: 647-654.
19. Popovich DG, Hu C, Durance TD, Kitts DD, (2005) Retention of ginsenosides in dried ginseng root: Comparison of drying methods. J Food Sci 70: s355-s358.
20. Kang KS, Yokozawa T, Yamabe N, Kim HY, Park JH, (2007) ESR study on the structure and hydroxyl radical-scavenging activity relationships of ginsenosides isolated from Panax ginseng CA Meyer. Biol Pharm Bull 30: 917-921.
21. Cui WG, Zhou Y, Chang J, (2010) Electrospun nanofibrous materials for tissue engineering and drug delivery. Sci Technol Adv Mater 11: 014108.
22. Cui WG, Qi MB, Li XH, Huang SZ, Zhou SB, et al. (2008) Electrospun fibers of acid-labile biodegradable polymers with acetal groups as potential drug carriers. Int J Pharm 361: 47-55.
23. Cui W, Zhu X, Yang Y, Li X, Jin Y, (2009) Evaluation of electrospun fibrous scaffolds of poly (DL-lactide) and poly (ethylene glycol) for skin tissue engineering. Mater Sci Eng: C 29: 1869-1876.
24. Cui WG, Li XH, Zhu XL, Yu G, Zhou SB, et al. (2006) Investigation of drug release and matrix degradation of electrospun poly (DL-lactide) fibers with paracetanol inoculation. Biomacromolecules 7: 1623-1629.
25. Kenawy ER, Abdel-Hay FI, El-Newehy MH, Wnek GE, (2009) Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 113: 296-302.
26. Sill TJ, Von Recum HA, (2008) Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 29: 1989-2006.
27. Yoo HS, Kim TG, Park TG, (2009) Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 61: 1033-1042.
28. Cui W, Li X, Zhou S, Weng J, (2007) Investigation on process parameters of electrospinning system through orthogonal experimental design. J Appl Polym Sci 103: 3105-3112.
29. Kim JS, Choi IG, Lee BC, Park JB, Kim JH, et al. (2012) Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts. Mol Cell Biochem 365: 181-189.
30. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, et al. (1997) Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 100:, 674.
31. Brown RJ, Lee-Michael J, Sisco M, Kim-John YS, Roy N, et al. (2008) High-dose ultraviolet light exposure reduces scar hypertrophy in a rabbit ear model. Plast Reconstr Surg 121: 1165-1172.
32. Tandara AA, Mustoe TA, (2008) The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel. Journal of Plastic, Reconstr Aesthet Surg 61: 1219-1225.
33. Joo EJ, Ha YW, Shin H, Son SH, Kim YS, (2009) Generation and characterization of monoclonal antibody to ginsenoside Rg3. Biol Pharm Bull 32: 548-552.
34. Wischke C, Schwendeman SP, (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 364: 298-327.
35. Sun S, Wang CZ, Tong R, Li XL, Fishbein A, et al. (2010) Effects of steaming the root of>Panax notoginseng on chemical composition and anticancer activities. Food Chem 118: 307-314.
36. Zeng J, Xu X, Chen X, Liang Q, Bian X, et al. (2003) Biodegradable electrospun fibers for drug delivery. J Control Release 92: 227-231.
37. Tan ST, Wendorff JH, Pietzonka C, Jia ZH, Wang GQ, (2005) Biocompatible and biodegradable polymer nanofibers displaying superparamagnetic properties. ChemPhysChem 6: 1461-1465.
38. He BC, Gao JL, Luo X, Luo J, Shen J, et al. (2011) Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling. Int J Oncol 38: 437-445.
39. Li L, Bellan LM, Craighead HG, Frey MW, (2006) Formation and properties of nylon-6 and nylon-6/montmorillonite composite nanofibers. Polymer 47: 6208-6217.
40. Toncheva A, Paneva D, Manolova N, Rashkov I, (2011) Electrospun poly (L-lactide) membranes containing a single drug or multiple drug system for antimicrobial wound dressings. Macromol Res 19: 1310-1319.
41. Verreck G, Chun I, Rosenblatt J, Peeters J, Dijcka AV, et al. (2003) Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. J Control Release 92: 349-360.
42. Yu DG, Gao LD, White K, Branford-White C, Lu WY, et al. (2010) Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug. Pharm Res 27: 2466-2477.
43. Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, et al. (2000) In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams. Biomaterials 21: 1837-1845.
44. Bölgen N, Menceloǧlu YZ, Acatay K, Vargel I, Pişkin E, (2005) In vitro and in vivo degradation of non-woven materials made of poly(ε-caprolactone) nanofibers prepared by electrospinning under different conditions. J Biomater Sci Polym Ed 16: 1537-1555.